Literature DB >> 6094199

Improvements and limitations of the subrenal capsule assay for determining tumour sensitivity to cytostatic drugs.

M B Edelstein, T Smink, D J Ruiter, W Visser, L M van Putten.   

Abstract

Cyclophosphamide (CY) prevented the host response from occurring in treated animals, and we therefore evaluated CY and other immunosuppressive forms of pretreatment in normal mice using the subrenal capsule assay initially for transplanted and later also for primary tumours. CY pretreatment, 4 or 4.5 Gy whole-body irradiation and cortisone were superior to silica in reducing host cell infiltration, and irradiation as pretreatment has become our routine technique. The addition of cortisone acetate to irradiation was of minor benefit in only 1/3 transplanted lines. When primary tumours were tested, the irradiation was only rarely able to completely prevent cellular infiltration. Only 7/11 ovarian tumours and 3/9 lung tumours were evaluable as tumour specimens (greater than 50% tumour) in preirradiated mice. The degree of infiltration and fibrosis was similar in transplants in irradiated normal mice or in athymic nude mice, suggesting that these phenomena are largely due to properties of the tumours rather than of the host. The limitations of the technique to some cell lines and occasional primary tumours is obvious.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094199     DOI: 10.1016/0277-5379(84)90149-4

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  4 in total

1.  The histological assessment and evaluation of a 4 day subrenal capsule assay by the percentage inhibition of DNA/protein.

Authors:  M Nishiyama; M Hirono; S Takagami; R Kim; T Saeki; Y Kirihara; K Jinushi; E Yanagawa; T Toge; M Niimoto
Journal:  Jpn J Surg       Date:  1989-07

2.  Comparative study on nude mice isotope assay (NM-IA) and subrenal capsule assay (SRCA) sensitivity tests of anticancer agents.

Authors:  M Nishiyama; Y Nosoh; M Yamaguchi; N Hirabayashi; T Toge; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1987-03

3.  Effectiveness of P-aminobenzoyl-O-phenylenediamine (Goe 1734) against mouse, rat, and human tumour cells.

Authors:  P Lelieveld; R J Middeldorp; L M van Putten
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  Microencapsulation of human cells: its effects on growth of normal and tumour cells in vitro.

Authors:  S M Shimi; D Hopwood; E L Newman; A Cuschieri
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.